1 Introduction Metabolic syndrome (MS) is a worldwide healthcare issue of increasing magnitude, with the number of cases projected to reach approximately 2.568 billion by 2040 ( In addition to active intervention and improvement of the patients lifestyle, the clinical treatment of MS focuses on individual or combined drug therapy for specific pathologic features to achieve reduction of insulin resistance, restoration of normal blood glucose, improvement of lipid metabolism disorders, and lowering of blood pressure
Market share erosion and gain analysis indicates that established therapies may face declining use as GLP-1 drugs capture increasing market share due to superior clinical outcomes
It has been demonstrated that the areas of the epidermis affected by vitiligo have a poor calcium metabolism, with low calcium uptake by melanocytes or an absence of L-type calcium channels (Schallreuter-Wood et al., 1996
When levels of vitamin B12, folic acid or vitamin B6 are low, homocysteine levels rise and hyperhomocysteinaemia can develop
Experience In Treating Pigmentation : Olivas dermatologists are highly experienced in treating all types and severities of pigmentation, from tanning to stubborn melasma
